Six policy lessons relevant to cannabis legalization

References

• Humphreys K, Piot P. Scientific evidence alone is not sufficient basis for health policy. BMJ. 2012;344:e1316. Doi: 10.1136/bmj.e1316.
   PubMed Web of Science ®Google Scholar
• Kilmer B. Considering cannabis legalization in Canada: prices, taxes, and international implications. Santa Monica (CA): RAND Corporation; 2017.
   Google Scholar
• Kilmer B. Should Canada “Start Low and Go Slow” when it comes to cannabis potency? Santa Monica (CA): RAND Corporation; 2018.
   Google Scholar
• Pacula RL, Kilmer B, Wagenaar AC, Chaloupka FJ, Caulkins JP. Developing public health regulations for marijuana: lessons from alcohol and tobacco. Am J Public Health. 2014;104(6):1021–28. doi:10.2105/AJPH.2013.301766.
   PubMed Web of Science ®Google Scholar
• Crepault JF. Cannabis legalization in Canada: reflections on public health and the governance of legal psychoactive substances. Front Public Health. 2018;6:7. doi:10.3389/fpubh.2018.00220.
   PubMed Web of Science ®Google Scholar
• Cole JM. Guidance regarding marijuana enforcement. Washington (DC): U.S. Department of Justice; 2013.
   Google Scholar
• Sessions JB. Marijuana Enforcement. Washington (DC): U.S. Department of Justice; 2018.
   Google Scholar
• Drug Enforcement Agency DoJ. Schedules of controlled substances: placement in schedule V of certain FDA-approved drugs containing cannabidiol; corresponding change to permit requirements. Silver Spring (MD): Federal Register, Justice Do; 2018 Sept 28. Contract No.: 189.
   Google Scholar
• Saint Louis C. Pregnant women turn to Marijuana, perhaps harming infants. The New York Times. 2017 Feb 2.
   Google Scholar
• Alcohol & Drug Abuse Institute. Legalization in the U.S.: University of Washington; 2017. http://learnaboutmarijuanawa.org/policy/us.htm#timelines.
   Google Scholar
• SB-94 Cannabis: medicinal and adult use. Sacramento, CA; 2017. https://leginfo.legislature.ca.gov/faces/billTextClient.xhtml?bill_id=201720180SB94.
   Google Scholar
• Maine revenue services sales fstd. Sales of medical Marijuana and related products. Augusta (ME): Maine Revenue Services Sales, Fuel & Special Tax Division; 2016.
   Google Scholar
• Maine State Legislature. Recreational Marijuana in Maine. Augusta, ME; 2018. https://legislature.maine.gov/9419.
   Google Scholar
• Oregon Department of Revenue. Marijuana tax program. Salem, OR; 2018. https://www.oregon.gov/DOR/programs/businesses/Pages/marijuana.aspx.
   Google Scholar
• Calonge N. Policy pitfalls and challenges in cannabis regulation: lessons from Colorado. Int J Mental Health Addict. 2018;16(4):783–90.
   Web of Science ®Google Scholar
• Pacula RL, Jacobson M, Maksabedian EJ. In the weeds: a baseline view of cannabis use among legalizing states and their neighbours. Addiction. 2016;111(6):973–80. doi:10.1111/add.13282.
   PubMed Web of Science ®Google Scholar
• Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. Toking, vaping, and eating for health or fun marijuana use patterns in adults, US, 2014. Am J Prev Med. 2016;50(1):1–8. doi:10.1016/j.amepre.2015.05.027.
   PubMed Web of Science ®Google Scholar
• Humphreys K. Mis-Imagining Marijuana Inc. Washington monthly. 2011 Jul 26.
   Google Scholar
• Barry RA, Hiilamo H, Glantz SA. Waiting for the opportune moment: the tobacco industry and marijuana legalization. Milbank Q. 2014;92(2):207–42. doi:10.1111/1468-0009.12055.
   PubMed Web of Science ®Google Scholar
• Isidore C. Coke could make a move into cannabis-infused drinks. New York (NY): CNN Money; 2018.
   Google Scholar
• Aaron DG, Siegel MB. Sponsorship of National Health Organizations by two major soda companies. Am J Prev Med. 2017;52(1):20–30. doi:10.1016/j.amepre.2016.08.010.
   PubMed Web of Science ®Google Scholar
• Humphreys K, Darke S, Marsden J, West R. Extending Addiction’s conflict of interest policy to cover the emerging cannabis industry. Addiction. 2018;113(2):205. doi:10.1111/add.14178.
   PubMed Web of Science ®Google Scholar
• Caulkins JP, Kilmer B, Kleinman MAR, MacCoun RJ, Midgette G, Oglesby P, Pacula RL, Reuter PH. Options and issues regarding Marijuana legalization. Santa Monica (CA): RAND Corporation; 2015.
   Google Scholar
• Miller T, Snowden C, Birckmayer J, Hendrie D. Retail alcohol monopolies, underage drinking, and youth impaired driving deaths. Accid Anal Prev. 2006;38(6):1162–67. doi:10.1016/j.aap.2006.05.003.
   PubMed Web of Science ®Google Scholar
• Holder HD, Wagenaar AC. Effects of the elimination of a state monopoly on distilled spirits’ retail sales: a time-series analysis of Iowa. Br J Addict. 1990;85(12):1615–25.
   PubMedGoogle Scholar
• Carlini BH. Potency increase, product development and marijuana marketing in times of legalization. Addiction. 2017;112(12):2178–79. doi:10.1111/add.13945.
   PubMed Web of Science ®Google Scholar
• Proctor RN. Golden holocaust: origins of the cigarette catastrophe and the case for abolition. Berkeley (CA): University of California Press; 2012.
   Google Scholar
• Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112(12):2167–77. doi:10.1111/add.13886.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–42. doi:10.1001/jamapsychiatry.2015.1858.
   PubMed Web of Science ®Google Scholar
• Hostiuc S, Moldoveanu A, Negoi I, Drima E. The association of unfavorable traffic events and cannabis usage: a meta-analysis. Frontiers in pharmacology. 2018. 9:99. doi: https://doi.org/10.3389/fphar.2018.00099.
   Google Scholar
• Borodovsky JT, Lee DC, Crosier BS, Gabrielli JL, Sargent JD, Budney AJ. US cannabis legalization and use of vaping and edible products among youth. Drug Alcohol Depend. 2017;177:299–306. doi:10.1016/j.drugalcdep.2017.02.017.
   PubMed Web of Science ®Google Scholar
• Freeman TP, van der Pol P, Kuijpers W, Wisselink J, Das RK, Rigter S, van Laar M, Griffiths P, Swift W, Niesink R, et al. Changes in cannabis potency and first-time admissions to drug treatment: a 16-year study in the Netherlands. Psychol Med. 2018;48(14):2346–52. doi:10.1017/S0033291717003877.
   PubMed Web of Science ®Google Scholar
• Humphreys K. Why states should limit the potency of marijuana. The Washington Post. 2018 Feb 7.
   Google Scholar
• Orenstein DG, Glantz SA. Regulating cannabis manufacturing: applying public health best practices from tobacco control. J Psychoact Drugs. 2018;50(1):19–32. doi:10.1080/02791072.2017.1422816.
   PubMed Web of Science ®Google Scholar
• Van Laar M, Van Der Pol P, Niesink R. Limitations to the Dutch cannabis toleration policy: assumptions underlying the reclassification of cannabis above 15% THC. Int J Drug Policy. 2016;34:58–64. doi:10.1016/j.drugpo.2016.02.011.
   PubMed Web of Science ®Google Scholar
• Griffith Edwards PA, Babor TF, Casswell S, Ferrence R, Giesbrecht N, Godfrey C, Holder HD, Paul HMM. Lemmens alcohol policy and the public good. Oxford (UK): Oxford University Press; 1995.
   Google Scholar
• Caulkins JP, Reuter P. What price data tell us about drug markets. J Drug Issues. 1998;28(3):593–612. doi:10.1177/002204269802800302.
   Web of Science ®Google Scholar
• Humphreys K. How legalization caused the price of marijuana to collapse. The Washington Post. 2017 September 5.
   Google Scholar
• Humphreys K. Marijuana is getting cheaper. For Some States, That’s a Problem. 2018 Nov 16.
   Google Scholar
• Wright A, Smith KE, Hellowell M. Policy lessons from health taxes: a systematic review of empirical studies. BMC Public Health. 2017;17. doi:10.1186/s12889-017-4497-z.
   Web of Science ®Google Scholar
• Elder RW, Lawrence B, Ferguson A, Naimi TS, Brewer RD, Chattopadhyay SK, Toomey TL, Fielding JE. The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms. Am J Prev Med. 2010;38(2):217–29. doi:10.1016/j.amepre.2009.11.005.
   PubMed Web of Science ®Google Scholar
• Ramirez RL, Jernigan DH. Increasing alcohol taxes: analysis of case studies from Illinois, Maryland, and Massachusetts. J Stud Alcohol Drugs. 2017;78(5):763–70.
   PubMed Web of Science ®Google Scholar
• Tax Guide for Cannabis Businesses CA.gov. 2018. http://www.cdtfa.ca.gov/industry/cannabis.htm#Facts.
   Google Scholar
• Stockwell T. Minimum unit pricing for alcohol: the most cost-effective of cancer prevention strategies? Expert Rev Anticancer Ther. 2017;17(11):981–83. doi:10.1080/14737140.2017.1381565.
   PubMed Web of Science ®Google Scholar
• Purshouse RC, Meier PS, Brennan A, Taylor KB, Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375(9723):1355–64. doi:10.1016/S0140-6736(10)60058-X.
   PubMed Web of Science ®Google Scholar
• Harris K. Crime in California, 2011. oag.ca.gov: office of the attorney general of California. Sacramento (CA): California Department of Justice; 2012.
   Google Scholar
• Maxwell JC, Mendelson B. What do we know now about the impact of the laws related to Marijuana? J Addict Med. 2016;10(1):3–12. doi:10.1097/ADM.0000000000000188.
   PubMed Web of Science ®Google Scholar
• Berman DA. Leveraging Marijuana Reform to Enhance Expungement Practices. SSRN Scholarly Paper. Rochester, NY: Social Science Research Network; 2018 04/18. Report No.: ID 3165001.
   Google Scholar
• National Academies of Sciences Engineering, and Medicine. The health effects of cannabis and cannabinoids: current state of evidence and recommendations for research. Washington (DC): The National Academies Press; 2017.
   Google Scholar
• Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet. 2009;374(9698):1383–91. doi:10.1016/S0140-6736(09)61037-0.
   PubMed Web of Science ®Google Scholar
• Marie O, Zolitz U. “High” achievers? Cannabis access and academic performance. Rev Econ Stud. 2017;84(3):1210–37.
   Web of Science ®Google Scholar
• Grucza RA, Agrawal A, Krauss MJ, Cavazos-Rehg PA, Bierut LJ. Recent trends in the prevalence of marijuana use and associated disorders in the United States. JAMA Psychiatry. 2016;73(3):300–01. doi:10.1001/jamapsychiatry.2015.3111.
   PubMed Web of Science ®Google Scholar
• Davenport SS, Caulkins JP. Evolution of the United States Marijuana market in the decade of liberalization before full legalization. J Drug Issues. 2016;46(4):411–27. doi:10.1177/0022042616659759.
   Web of Science ®Google Scholar
• U.S. Food and Drug Administration. FDA and Marijuana 2018 [accessed 2018 Nov 21]. https://www.fda.gov/newsevents/publichealthfocus/ucm421163.htm.
   Google Scholar
• U.S. Food and Drug Administration. What is a botanical drug? 2017 [accessed 2017 Aug 14]. https://www.fda.gov/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm090983.htm.
   Google Scholar
• Humphreys K. The paradox at the heart of our marijuana laws — and how to fix it. Washington Post. 2016 Apr 26.
   Google Scholar
• Abrams DI, Couey P, Shade SB, Kelly ME, Benowitz NL. Cannabinoid-opioid interaction in chronic pain. Clin Pharmacol Ther. 2011;90(6):844–51. doi:10.1038/clpt.2011.188.
   PubMed Web of Science ®Google Scholar
• Boehnke KF, Litinas E, Clauw DJ. Medical Cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739–44. doi:10.1016/j.jpain.2016.03.002.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Sabioni P, Trigo JM, Ware MA, Betz-Stablein BD, Murnion B, Lintzeris N, Khor KE, Farrell M, Smith A, et al. Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology. 2017;42(9):1752–65. doi:10.1038/npp.2017.51.
   PubMed Web of Science ®Google Scholar
• Humphreys KFJ, Sox-Harris A, Kivlahan D. Mind the brain [Internet]. PLOS Blogs. 2015 [accessed 2018]. https://blogs.plos.org/mindthebrain/2015/04/28/what-the-pot-and-pain-pill-overdose-study-teaches-us-about-ecological-fallacies/.
   Google Scholar
• Olfson M, Wall MM, Liu S, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry. 2018;175(1):47–53. doi:10.1176/appi.ajp.2017.17040413.
   PubMed Web of Science ®Google Scholar
• Caputi TL, Humphreys K. Medical marijuana users are more likely to use prescription drugs medically and nonmedically. J Addict Med. 2018;12(4):295–99. doi:10.1097/ADM.0000000000000405.
   PubMed Web of Science ®Google Scholar
• Campbell G, Hall WD, Peacock A, Lintzeris N, Bruno R, Larance B, Nielsen S, Cohen M, Chan G, Mattick RP, et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3(7):E341–E50. doi:10.1016/S2468-2667(18)30110-5.
   PubMed Web of Science ®Google Scholar
• Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction. 2005;100(10):1518–25. doi:10.1111/j.1360-0443.2005.01220.x.
   PubMed Web of Science ®Google Scholar
• Ramo DE, Delucchi KL, Hall SM, Liu H, Prochaska JJ. Marijuana and tobacco co-use in young adults: patterns and thoughts about use. J Stud Alcohol Drugs. 2013;74(2):301–10.
   PubMed Web of Science ®Google Scholar